Dr. Gary Novack presented an invited talk on “Why are there not more new glaucoma drugs” at the August meeting of the Glaucoma Research Society. The Glaucoma Research Society is a public interest, non-profit scientific association of outstanding glaucoma researchers that provides a forum to discuss and stimulate compelling or innovative research to prevent glaucoma-related disability worldwide. It is limited to 100 members worldwide. Dr. Novack is a long-time member.
Gary D. Novack, PhD, president of PharmaLogic Development
Dr. Novack speaking at ASCRS 2014
Dr. Novack talked in two symposia at the Glaucoma 360 event of the Glaucoma Research Foundation in San Francisco.
PharmaLogic sponsor a northern California bicycle riding team “Caballo Rojo
UCSC Chancellor George Blumenthal and Foundation President Ken Doctor thank Dr. Novack for his service to UCSC.
Dr. Novack on floor of California State Assembly with Assemblymember Beall (D-San Jose)
Dr. Novack addresses European Glaucoma Society on Generic Drugs
Dr. Novack with Dr. Wiley Chambers (FDA/CDER), Dr. Ellen Strahlman (CMO GSK), and Dr. Malvina Eydelman (FDA/CDRH) at the Glaucoma 360 event.
Dr. Novack speaking at International Symposium on Ocular Pharmacology and Therapeutics, Vienna, Austria
Dr. Elizabeth Moyer and Dr. Novack at ophthalmology workshop European Medicines Agency
Dr. Novack presents young investigator award at ASPET to Stephanie Piecewicz of MIT